Skip to content

Biocon Biologics Ltd. (BBL), a subsidiary of Biocon Ltd., is a fully integrated, global biosimilars company committed to transforming healthcare and transforming lives by enabling affordable access to biosimilars for millions of patients worldwide. It is leveraging cutting-edge science, innovative tech platforms, global scale manufacturing capabilities and world-class quality systems to lower costs of biological therapeutics while improving healthcare outcomes.

Biocon Biologics has commercialized eight biosimilars globally and has a pipeline of 20 biosimilar assets across diabetology, oncology, immunology, ophthalmology.

Biocon was founded by Kiran Mazumdar-Shaw, a first-generation entrepreneur who started her biotech business in 1978 in India and built a global business with over 4 decades of experience in biotechnology, contributing to offer accessible and affordable treatments to millions of patients worldwide.

Biocon Biologics was founded in 2019, and in 2023 it acquired Viatris’ global biosimilars business to become a fully integrated global biosimilars company with end-to-end capabilities from “lab-to-market” and a broad portfolio.

Biocon Biologics is focused on accelerating growth for existing products while simultaneously expanding its geographical footprint and launching new products.

Visit Website: www.bioconbiologicseu.com

×

Join us in Prague at the special rate of
350 Euro*(+ 21% Czech VAT)
to promote
WORLD PHARMACIST DAY 2025!

Secure your spot (only 45 seats available!)

*instead of 400 Euro – Offer available from 25/09 at 00h01 to 30/09 at 23h59 CET

×

Join us in Prague for

the 2nd edition of BOOST!

Secure your spot (limited seats available!)

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy — the shortage of medicine and medical devices.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.